Objectives Our objectives were to estimate the public health outcomes of vaccinating Belgian children using an intranasal tetravalent live-attenuated influenza vaccine (QLAIV) combined with current coverage of high-risk/elderly individuals using the trivalent inactivated vaccine. Methods We used a deterministic, age-structured, dynamic model to simulate seasonal influenza transmission in the Belgian population under the current coverage or after extending vaccination with QLAIV to healthy children aged 2-17 years. Differential equations describe demographic changes, exposure to infectious individuals, infection recovery, and immunity dynamics. The basic reproduction number (R-0) was calibrated to the observed number of influenza doctor visits/year. Vaccine efficacy was 80 % (live-attenuated) and 59-68 % (inactivated). The 10-year incidence of symptomatic influenza was calculated with different coverage scenarios (add-on to current coverage). Results Model calibration yielded R-0 = 1.1. QLAIV coverage of 75 % of those aged 2-17 years averted 374,000 symptomatic cases/year (57 % of the current number), 244,000 of which were among adults (indirect effect). Vaccinating 75 % of those aged 2-11 years and 50 % of those aged 12-17 years averted 333,200 cases/year (213,000 adult cases/year). Vaccinating only healthy children aged 2-5 years generated direct protection but limited indirect protection, even with 90 % coverage (40,800 averted adult cases/year; -8.4 %). Targeting all children averted twice as many high-risk cases as targeting high-risk children only (8485 vs. 4965/year with 75 % coverage). Sensitivity analyses showed the robustness of results. Conclusions The model highlights the direct and indirect protection benefits when vaccinating healthy children with QLAIV in Belgium. Policies targeting only high-risk individuals or the youngest provide limited herd protection, as school-age children are important influenza vectors in the community.
机构:
Ctr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd MS A-32, Atlanta, GA 30329 USA
Ctr Dis Control & Prevent, Epidem Intelligence Serv, Influenza Div, 1600 Clifton Rd MS A-32, Atlanta, GA 30329 USACtr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd MS A-32, Atlanta, GA 30329 USA
Millman, Alexander J.
Reynolds, Sue
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd MS A-32, Atlanta, GA 30329 USACtr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd MS A-32, Atlanta, GA 30329 USA
Reynolds, Sue
Duffy, Jonathan
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Dis Control & Prevent, Immunizat Safety Off, Div Healthcare Qual Promot, 1600 Clifton Rd MS D-26, Atlanta, GA 30329 USACtr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd MS A-32, Atlanta, GA 30329 USA
Duffy, Jonathan
Chen, Jufu
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd MS A-32, Atlanta, GA 30329 USACtr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd MS A-32, Atlanta, GA 30329 USA
Chen, Jufu
Gargiullo, Paul
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd MS A-32, Atlanta, GA 30329 USACtr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd MS A-32, Atlanta, GA 30329 USA
Gargiullo, Paul
Fry, Alicia M.
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd MS A-32, Atlanta, GA 30329 USACtr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd MS A-32, Atlanta, GA 30329 USA